Breaking News Bar

Business News and Information

AstraZeneca Says Its COVID-19 Vaccine Produces Robust Immune Response In Elderly Patients

Days after US regulators gave the AstraZeneca - Oxford vaccine the green light to re-start its US-based trials, the FT is reporting new data that seems promising, even if it's still pretty preliminary.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear